Autor:	E García, CA Arce, H Bierschwale, A Aguirre
Jazyk:	angličtina
Předmět:	Cost effectiveness medicine.drug_class business.industry Health Policy Public Health Environmental and Occupational Health Monoclonal antibody medicine.disease Etanercept Rheumatoid arthritis Immunology medicine In patient Tumor necrosis factor alpha business medicine.drug
Zdroj:	Value in Health. (7):A522-A523
ISSN:	1098-3015
DOI:	10.1016/S1098-3015(10)75481-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e272836b8037845fa6373d7e9054296 Zobrazit plný text záznamu